PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
27-Sep-2024 LEO Pharma Presents Late-Breaking Results from the Phase 2a Mechanism of Action Trial of Temtokibart and Dupilumab in Moderate-to-Severe Atopic Dermatitis at the 2024 EADV Annual Meeting LEO Pharma A/S
27-Sep-2024 Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology Orion Corporation and Aitia
27-Sep-2024 Bayer News - AskBio to collaborate with Belief BioMed to explore the potential of new gene therapies Bayer AG
27-Sep-2024 PolTREG starts preclinical CAR-Treg development for neuroinflammatory autoimmune diseases PolTREG S.A.
27-Sep-2024 SOLARIO study meets its primary endpoints - Bone substitute with local antibiotics enables reduced systemic antibiotic treatment SOLARIO
27-Sep-2024 Call for Speakers: Upcoming Careers Event with Future Biotechnologists Future Biotechnologists
27-Sep-2024 CD Genomics Launches PacBio SMRT Sequencing Services to Revolutionize Genomic Research CD Genomics
27-Sep-2024 CD Genomics Introduces CircRNA Sequencing Service to Enhance Genomic Research CD Genomics
26-Sep-2024 Rousselot and xolo Strengthen Collaboration in 3D Bioprinting Research with Co-Branding Agreement Rousselot
26-Sep-2024 Unleash the Potential of Serum Untargeted Metabolomics with Creative Proteomics Creative Proteomics
26-Sep-2024 Creative Proteomics Launches Advanced Protein Purity and Homogeneity Characterization Service Creative Proteomics
26-Sep-2024 Amerigo Scientific Unveils Customized Fermenters Aimed at Expanding Access to Flexible Fermentation Tanks Amerigo Scientific
25-Sep-2024 Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology Orion
25-Sep-2024 New data show Almirall´s EBGLYSS® (lebrikizumab) provided sustained disease control for up to three years in more than 80% of adults and adolescents with moderate-to-severe atopic dermatitis Almirall
25-Sep-2024 Arctoris announces strategic partnership with Alphabet company, Isomorphic Labs Arctoris
25-Sep-2024 Royal Columbian Hospital Foundation’s Advancing Innovation in Medicine (AIM) division supports Steriwave ICU use with clinical trials at Royal Columbian Hospital Ondine Biomedical Inc
25-Sep-2024 Panthera moves back into recruiting and running commercial oncology clinical trials in the UK Panthera Biopartners
25-Sep-2024 AlgoTx Announces “Last Patient Last Visit” in International Phase II Trial of ATX01 in Chemotherapy-Induced Peripheral Neuropathy AlgoTherapeutix
25-Sep-2024 Creative Enzymes Unveils Innovative Bacteriophage Solutions to Combat Antibiotic Resistance Creative Enzymes
25-Sep-2024 Creative Enzymes Introduces Advanced Enzyme Solutions for mRNA Production Creative Enzymes